INVIVO THERAPEUTICS HOLDINGS CORP.
DelistedCIK 1292519fmd_06KXF0SQHQ93T5G10Q2B0XR0CBManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2008 to Sep 30, 2023, 56 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | 11 | 10 | 10 | 13 | 11 | 5 | 6 | 4 | 4 | 5 |
| Total operating expenses | 19 | 18 | 22 | 24 | 25 | 13 | 11 | 9 | 10 | 11 |
| Operating income | (19) | (18) | (22) | (24) | (25) | (13) | (11) | (9) | (10) | (11) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – |
| Other non-operating income (expense) | (20) | (1) | (11) | 1 | (2) | (11) | (0) | 0 | 0 | 0 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | (39) | (18) | (33) | (23) | (27) | (23) | (12) | (9) | (10) | (10) |
| Net income to common shareholders | – | (18) | (33) | (23) | – | – | – | (9) | (10) | (10) |